Amneal Pharmaceuticals (AMRX)
(Delayed Data from NSDQ)
$6.99 USD
-0.19 (-2.65%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $6.98 -0.01 (-0.14%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth C Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/09/2024
Time: BMO |
6/2024 | $0.14 | -16.28% |
Earnings Summary
For their last quarter, Amneal Pharmaceuticals (AMRX) reported earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.09 per share. This reflects a positive earnings surprise of 55.56%. Look out for AMRX's next earnings release on August 09, 2024. For the next earning release, we expect the company to report earnings of $0.14 per share, reflecting a year-over-year decrease of 26.32%.
Earnings History
Price & Consensus
Zacks News for AMRX
Earnings Preview: Amneal Pharmaceuticals (AMRX) Q2 Earnings Expected to Decline
AMRX: What are Zacks experts saying now?
Zacks Private Portfolio Services